Use of melanocortins to treat insulin sensitivity

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/08 (2006.01) A61P 5/50 (2006.01)

Patent

CA 2704651

The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 re-ceptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance.

La présente invention porte sur des ligands peptidiques des récepteurs de la mélanocortine, en particulier le récepteur de la mélanocortine-4, et, en tant que tels, sont utiles dans le traitement de troubles sensibles à l'activation de ce récepteur, tels que la résistance à l'insuline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of melanocortins to treat insulin sensitivity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of melanocortins to treat insulin sensitivity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of melanocortins to treat insulin sensitivity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1672165

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.